JOEL YOUNG: Open Payments
NPI 1356325468 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612,439 in 76 payments from 7 companies in 2025. Trend: 2023 $110,833 · 2024 $74,149 · 2025 $612,439
Grant: $540,781Honoraria: $44,270Speaker / faculty: $10,770Consulting: $6,521Travel & lodging: $4,749Speaker / faculty: $3,300
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 13 | $553,686 |
| Supernus Pharmaceuticals, Inc. | 33 | $35,992 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $13,459 |
| Collegium Pharmaceutical, Inc. | 5 | $5,735 |
| Noven Therapeutics, LLC | 4 | $3,425 |
| Lundbeck LLC | 2 | $126 |
| ABBVIE INC. | 1 | $16 |
Products named: Dyanavel XR, Qelbree, CAPLYTA, Jornay PM, Xelstrym, REXULTI, VRAYLAR.
Industry payments across MI — which companies pay providers there.
